Medplus Health Services Limited Stock Price Today (NSE: MEDPLUS)
Fundamental Score
Medplus Health Services Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medplus Health Services Limited share price today is ₹656.10, down 0.03% on NSE/BSE as of 16 September 2026. Medplus Health Services Limited (MEDPLUS) is a Mid-cap company in the Pharmacy Retail sector with a market capitalisation of ₹7.88K (Cr). The 52-week high for MEDPLUS share price is ₹1022.20 and the 52-week low is ₹645.00. At a P/E ratio of 37.41x, MEDPLUS is currently trading below its industry average P/E of 44.45x. The company has a Return on Equity (ROE) of 11.82% and a debt-to-equity ratio of 0.00.
Medplus Health Services Limited Share Price Chart — NSE/BSE Historical Performance
Medplus Health Services Limited share price chart: -2.38% return over the past month. 52-week high ₹1022.20, 52-week low ₹645.00.
Medplus Health Services Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹656.05 | ₹660.65 | ₹645.00 | ₹656.10 | 1.14L (Cr) | |
| ₹660.45 | ₹666.60 | ₹654.00 | ₹656.30 | 61.60K (Cr) | |
| ₹658.00 | ₹661.45 | ₹654.00 | ₹660.15 | 78.31K (Cr) | |
| ₹669.95 | ₹669.95 | ₹655.00 | ₹658.05 | 61.42K (Cr) | |
| ₹664.00 | ₹677.95 | ₹660.90 | ₹669.95 | 72.74K (Cr) | |
| ₹656.00 | ₹667.00 | ₹655.80 | ₹663.45 | 76.13K (Cr) | |
| ₹670.00 | ₹672.05 | ₹656.55 | ₹659.70 | 1.51L (Cr) | |
| ₹660.65 | ₹691.35 | ₹650.20 | ₹676.35 | 3.11L (Cr) | |
| ₹667.80 | ₹670.05 | ₹648.00 | ₹660.65 | 1.90L (Cr) | |
| ₹673.05 | ₹673.10 | ₹657.00 | ₹659.95 | 73.12K (Cr) |
Medplus Health Services Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹672.25 | ₹691.35 | ₹645.00 | ₹656.10 | -2.40% | |
| ₹704.95 | ₹708.75 | ₹648.00 | ₹672.25 | -4.64% | |
| ₹815.90 | ₹832.00 | ₹695.00 | ₹704.95 | -13.60% | |
| ₹890.00 | ₹909.35 | ₹796.70 | ₹810.75 | -8.90% | |
| ₹872.15 | ₹1022.20 | ₹852.20 | ₹895.20 | +2.64% | |
| ₹844.05 | ₹916.00 | ₹814.00 | ₹872.15 | +3.33% | |
| ₹802.60 | ₹858.90 | ₹793.40 | ₹839.90 | +4.65% | |
| ₹811.80 | ₹905.00 | ₹804.25 | ₹847.60 | +4.41% | |
| ₹805.00 | ₹854.90 | ₹759.00 | ₹798.95 | -0.75% | |
| ₹810.95 | ₹829.90 | ₹785.15 | ₹807.30 | -0.45% | |
| ₹787.00 | ₹868.00 | ₹749.45 | ₹808.80 | +2.77% | |
| ₹752.95 | ₹797.45 | ₹732.00 | ₹762.85 | +1.31% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medplus Health Services Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medplus Health Services Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDPLUS across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Revenue Growth (21.84%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (17.56% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (28.65% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Healthy Liquidity Position (Current Ratio: 3.20)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹886.44 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 43.35%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
4 factors identified
Profit Decline Concern (-21.68%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-57.75% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
High Share Pledging Risk (60.74%)
Observation: Significant promoter share pledging creates potential overhang.
Analysis: High pledging levels may create selling pressure during market downturns.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medplus Health Services Limited vs Pharmacy Retail Peers
Peer Comparison - Pharmacy Retail
Compare Medplus Health Services Limited with 1 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medplus Health Services LimitedMedplus Health ...Selected✓ MEDPLUS • 543427 | 38.4/100 | ₹656.10₹656 | ₹7882.06₹7882.06 | 37.41Average 37.4 Average | 11.82%Average 11.82% Average | 13.14%Average 13.14% Average | 0.00Excellent 0.0 Excellent | 28.65%Excellent 28.65% Excellent | 17.56%Excellent 17.56% Excellent | 0.00% |
Entero Healthcare Solutions LimitedEntero Healthca... ENTERO • 544122 | 55/100 | ₹1788.80₹1789 | ₹7785.39₹7785.39 | 62.07Average 62.1 Average | 6.74%Poor 6.74% Poor | 12.08%Average 12.08% Average | 0.34Excellent 0.3 Excellent | 57.46%Excellent 57.46% Excellent | 30.03%Excellent 30.03% Excellent | 0.00% |
Medplus Health Services Limited PE Ratio History
Historical price-to-earnings ratio for MEDPLUS — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹12.52 | ₹807.30 | 64.5x |
| FY 2024 | ₹5.45 | ₹830.85 | 152.4x |
| FY 2023 | ₹4.17 | ₹750.75 | 180x |
| FY 2022 | ₹8.52 | ₹613.60 | 72x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Medplus Health Services Limited Quarterly Performance
Latest quarterly metrics for MEDPLUS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
21.84%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-21.68%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
17.56%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
28.65%
Compounded annual net profit growth over 5 years
Medplus Health Services Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDPLUS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medplus Health Services Limited Financial Statements
Annual income statement, balance sheet and cash flow for Medplus Health Services Limited (MEDPLUS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Medplus Health Services Limited
About MEDPLUS (Medplus Health Services Limited)
Medplus Health Services Ltd is a ubiquitous presence in the Indian pharmacy retail landscape, distinguished by its extensive network of strategically located stores. More than just... a place to purchase medication, Medplus offers a comprehensive healthcare destination. Shelves are stocked with an array of pharmaceuticals, ranging from essential prescription drugs to readily available over-the-counter remedies. Beyond traditional medicines, Medplus caters to a growing health-conscious consumer base by providing a wide selection of wellness products, including vitamins, nutritional supplements, and medical devices designed for home use. This commitment to diverse product offerings positions Medplus as a one-stop shop for individuals seeking both curative and preventative healthcare solutions. The reach of Medplus extends beyond prescription fulfillment and over-the-counter sales. The company has diversified its offerings to include fast-moving consumer goods, recognizing the convenience and value of integrating everyday household essentials into its retail environment. Customers can find a variety of personal care items, such as toiletries, soaps, and sanitizers, alongside baby care products and cleaning supplies. This strategic inclusion of FMCG items enhances the shopping experience, making Medplus a convenient location for customers to address multiple needs in a single trip. The company's commitment to quality and value ensures that customers have access to reliable and affordable products across all categories. Beyond its retail presence, Medplus operates a wholesale division, catering to smaller pharmacies and healthcare providers through a cash-and-carry model. This business segment contributes to the broader accessibility of pharmaceuticals and healthcare products across the Indian market. In addition to product sales, Medplus also offers diagnostic services, further solidifying its position as a comprehensive healthcare provider. This multifaceted approach, encompassing retail, wholesale, and diagnostic services, sets Medplus apart in the competitive pharmacy retail sector, offering a holistic approach to meeting the diverse healthcare needs of its customers.
Company Details
Key Leadership
MEDPLUS Share Price: Frequently Asked Questions
What is the current share price of Medplus Health Services Limited?
Medplus Health Services Limited (MEDPLUS) trades at ₹656.10 on NSE and BSE. Market cap ₹7.88K (Cr). Educational data only.
What is the P/E ratio of Medplus Health Services Limited?
Medplus Health Services Limited has a P/E of 37.41x vs industry average 44.45x.
What is the Bull Run score for Medplus Health Services Limited?
Medplus Health Services Limited has a Bull Run score of 38.4/100 based on 25+ financial parameters.
Does Medplus Health Services Limited pay dividends?
Medplus Health Services Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medplus Health Services Limited?
Medplus Health Services Limited has ROE of 11.82%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medplus Health Services Limited?
Medplus Health Services Limited has debt-to-equity of 0.00.
Is Medplus Health Services Limited a good investment?
Bull Run gives Medplus Health Services Limited a score of 38.4/100. This is not investment advice — consult a SEBI-registered advisor.